Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Artificial pancreas Stories

2011-06-28 07:30:57

(Ivanhoe Newswire) --  The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. "The effects of low-intensity physical activity, mimicking activities of daily living, measured with precise accelerometers on glucose variability in type 1 diabetes had not been examined," ...

2011-06-27 12:17:32

The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. As part of this effort, Drs. Kudva and Basu will present their latest findings on how the mundane movements of everyday life affect blood sugar to the American Diabetes...

2011-06-22 14:57:00

Concerns about progress, patient access voiced at Senate hearing for JDRF's Children's Congress WASHINGTON, June 22, 2011 /PRNewswire-USNewswire/ -- Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee on Homeland Security and Government Affairs. The hearing, "Transforming Lives through Diabetes Research," was...

2011-06-20 18:18:00

WASHINGTON, June 20, 2011 /PRNewswire-USNewswire/ -- On Wednesday, actor Kevin Kline and children with type 1 diabetes from all over the country will testify before the Senate Committee on Homeland Security and Government Affairs to thank Congress for its renewal last December of the Special Diabetes Program and highlight the importance of the federal government's commitment in helping to advance type 1 diabetes research. They will also urge federal officials to take immediate action to...

2011-06-20 11:51:00

Guidance outlines recommendations for clinical trials and pathway to market approval SILVER SPRING, Md., June 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Type 1 diabetes is a chronic condition in which the pancreas produces little or no...

2011-06-16 08:00:00

WORCESTER, Mass. and TORONTO, June 16, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) today issued a synopsis of the update on the clinical and regulatory program for Generex Oral-lyn(TM), the Company's proprietary buccal insulin spray product, provided at the annual meeting of the Company's stockholders held in New York City on June 8, 2011. At that meeting, the current status, clinical study plans, and major market registration pathway for Generex...

2011-06-13 11:37:00

Singer Crystal Bowersox, Olympic swimmer Gary Hall Jr. among others joining children and teens with type 1 diabetes on Capitol Hill to advocate for diabetes research; Live webcast of "Role Models with Type 1 Diabetes" Town Hall Panel available WASHINGTON, June 13, 2011 /PRNewswire-USNewswire/ -- Leading figures from the entertainment, television, and professional sports arenas will join more than 150 children and teenage delegates from all over the United States and abroad, as well as...

2011-06-06 19:58:18

Rensselaer Polytechnic Institute Researchers Play Key Role in Development of "Closed Loop" Artificial Pancreas Engineering researchers at Rensselaer Polytechnic Institute are combining automation techniques from oil refining and other diverse areas to help create a closed-loop artificial pancreas. The device will automatically monitor blood sugar levels and administer insulin to patients with Type 1 diabetes, and aims to remove much of the guesswork for those living with the chronic disease....

2011-06-06 15:14:05

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of curing a disease that affects 3 million Americans. "With just one injection of this gene therapy, the mice remain diabetes-free long term and have a return of normal insulin levels in the body," said Vijay Yechoor, MD, the principal investigator and an assistant professor at...

2011-05-11 08:00:00

WEST CHESTER, Pa., May 11, 2011 /PRNewswire/ -- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for people living with diabetes. The increased collaboration also will include more closely aligning their commercial organizations to actively co-promote their product offerings, such as the...